The Department of Veterans Affairs (VA) Veterans Health Administration has awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, for immunochemistry and immunohistochemistry laboratory testing services. The single-award IDC, valued at $2.3 million, was awarded on November 13, 2020 and has an ultimate completion date of November 12, 2025. Under this IDC, the VA has placed multiple firm fixed price delivery orders with Roche...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a series of firm fixed price delivery orders under an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The total ceiling value of the IDC is $2,403,690.00, with the most recent delivery order valued at $480,738.00 and a performance period ending on September 30, 2025. The delivery orders are...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics. The $487,747.35 BPA contract, issued under the GSA Schedule Critical Analyzers, Laboratory (FSS-66-III), will provide the VA with critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services. The contract supports the provision of...
The Department of Veterans Affairs (VA), Veterans Integrated Service Network 9 awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The base contract, valued at $922,772, provides the VA with an ongoing vehicle to procure influenza A/B and COVID-19 testing supplies and services without socioeconomic set-asides. Under this IDC, the VA has issued multiple firm...
The U.S. Department of Veterans Affairs (VA) awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at up to $15,466,932.92, is for the rental of Molecular Diagnostics Analyzers and associated reagents to support the VA's laboratory testing capabilities across its healthcare facilities. Two delivery orders have been issued...
The Department of Veterans Affairs (VA) has awarded Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics and medical equipment, multiple Indefinite Delivery Vehicles (IDVs) and Blanket Purchase Agreements (BPAs) through the General Services Administration (GSA) Multiple Award Schedule (MAS) contract. These IDVs and BPAs, valued between $400,000 and $520,000, provide Roche's critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies,...
The Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) valued at $167,300 to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical laboratory equipment. The contract, which has a period of performance through June 30, 2030, provides for the delivery of Roche LIAT consumables, including test kits and controls for COVID-19, Influenza A/B, RSV, and Group A Streptococcus testing, to the VA's Veterans...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, for the procurement of Ventana immunohistochemical reagents and associated laboratory equipment, supplies, and services. This single-award IDC has a potential value of $2,442,399.60 over a 5-year ordering period from March 2024 to March 2029. Under this IDC, the VA VHA Network Contracting Office 17...
The Department of Veterans Affairs Veterans Health Administration has awarded Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a single-award indefinite delivery contract (IDC) to provide Roche brand reagents and consumables. The $100,685.04 firm fixed price delivery order has a period of performance through February 2027 and does not utilize any set-asides. Roche Diagnostics Corp, a foreign-owned for-profit manufacturer, is an established federal contractor that has...
The Department of Veterans Affairs Veterans Health Administration (VA VHA) awarded a single-award indefinite delivery contract (IDC) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics and laboratory instruments, to provide reagents, supplies, and consumables for Roche-manufactured Cobas 6800/8800 laboratory instruments. The $1,170,000 IDC has a 5-year ordering period ending on September 30, 2026. Under this IDC, the VA VHA has awarded multiple delivery orders to Roche...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, an Indefinite Delivery Contract (IDC) to provide molecular pathology products and services. Under this IDC, the VA has issued multiple firm fixed-price delivery orders to Roche Diagnostics over a 5-year period, with a total ceiling value of $3,000,000. The delivery orders will supply clinical chemistry analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to support healthcare services for veterans at VA facilities nationwide. This procurement was not set aside for any socioeconomic program. The delivery orders leverage Roche's existing General Services Administration (GSA) Schedule contracts and other IDVs to streamline the VA's ability to acquire essential medical equipment and consumables on an as-needed basis.
The original solicitation sought FDA-approved molecular pathology analyzers and associated supplies to support the clinical laboratory at the VA's Edward Hines, Jr. Hospital in Illinois. Key requirements included bi-directional electronic interfaces with the VA's VistA healthcare IT system, automated sample processing, and compliance with CLIA and CLSI standards for accuracy and precision. Roche Diagnostics was able to demonstrate that its instrumentation, reagents, and technical support services met these criteria, enabling the VA to award this long-term IDC to streamline procurement of these critical laboratory capabilities.